The aim of this study was to test the hypothesis that aging with sustained glucose intake, which reduces availability of cerebral GLP-1R, contributes to cognitive decline of the brain, leading to CH and/or AD depending on functionality of metabolic clearance. The gene discussed is GLP1R; the disease is Alzheimer disease.